The healthcare expenditure on immunisation programmes in the UK stood at 16.46 percent euros per capita in 2023. For the upcoming years, the expenditure is forecasted to increase gradually: 16.61 percent in 2024, 16.76 percent in 2025, 16.91 percent in 2026, and 17.05 percent in 2027. From 2023 to 2024, the year-on-year variation shows an increase of approximately 0.91%. Subsequently, each year maintains a similar upward trend with a consistent approximate increase of 0.91% year-on-year. From 2023 to 2027, the Compound Annual Growth Rate (CAGR) is predicted to be around 0.90% annually over the five-year period.
Looking ahead, the focus will be on monitoring vaccine innovation, changing population demographics, and government policy changes which could impact both funding and the prioritization of immunisation programmes.
Latest reports
US Vaccine Market Report- Q1 2025
The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...
China Vaccine Market Report- Q1 2025
The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...
Japan Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...
Germany Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...
India Vaccine Market Report- Q4 2024
The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...
UK Vaccine Market Report- Q4 2024
The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...
France Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...
Canada Vaccine Market Report- Q4 2024
The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...
Brazil Vaccine Market Report- Q4 2024
The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...
Italy Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...